neurostimulation system

DEVICE2 trials

Sponsors

Boston Scientific Corporation

Conditions

PainPain, Chronic

Unknown Phase

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

RecruitingNCT01719055

Boston Scientific CorporationPain

Start: 2012-11-19End: 2035-05-01Target: 4800Updated: 2026-09-11

NAVITAS and ENVISION - Study to Characterize Select Objective Metrics & Clinical Outcomes in Chronic Pain Patients With Boston Scientific Neurostimulation Systems

CompletedNCT03240588

Boston Scientific CorporationPain, Chronic

Start: 2017-07-31End: 2024-03-08Updated: 2025-05-08

Related Papers

Defining and validating a multidimensional digital metric of health states in chronic back and leg pain.

2025-11-21

854-P: Global, Multicenter Registry of Prospectively-Enrolled Patients Utilizing SCS for Chronic Pain—Long-Term Outcomes from a Subcohort Diagnosed with Painful Diabetic Peripheral Neuropathy

Diabetes2024-06-14

A Recommender for the Management of Chronic Pain in Patients Undergoing Spinal Cord Stimulation

2023-07-015 citations

Long-term Safety of Spinal Cord Stimulation Systems in A Prospective, Global Registry of Patients With Chronic Pain

Pain Management2023-01-2425 citations

ESRA19-0159 A prospective global registry of real-world outcomes using spinal cord stimulation systems for chronic pain

2019-08-301 citations